Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_assertion type Assertion NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_head.
- NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_assertion wasGeneratedBy ECO_0000203 NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_provenance.
- NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_assertion wasDerivedFrom lhgdn-20090331 NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_provenance.
- NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_assertion SIO_000772 19028704 NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_provenance.
- NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_assertion evidence source_evidence_literature NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_provenance.
- NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_provenance.